Barbacid Study Removed After Fundraising Efforts.

A study about cancer treatment was pulled by the National Academy of Sciences. Mariano Barbacid was involved, and it was because of a company he owned. The study was about mice and claimed a new treatment.
The study, led by Mariano Barbacid, initially suggested a successful treatment for pancreatic cancer using research on mice. However, a review in February found that Barbacid, Carmen Guerra, and Vasiliki Liaki were also owners of Vega Oncotargets. This company was working on cancer therapies. The conflict of interest was not revealed when the study was first presented. Because of this, the National Academy of Sciences retracted the study.
Summarized from the sources above. Read the originals for the full story.
Highlights
Barbacid Continued Fundraising
Mariano Barbacid raised money for six weeks after the study was withdrawn.
Study Was Retracted
The study about pancreatic cancer was officially retracted due to conflict of interest.
Conflict of Interest Found
Barbacid, Guerra, and Liaki were co-owners of Vega Oncotargets.
Claims Were False
The study claimed an effective treatment for pancreatic cancer.
Academy Removed Study
The US National Academy of Sciences removed the study from the journal.